Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

AbCellera Biologics Inc. (ABCL)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1
Revenues:  
    CANADA  484.2353.4   
    UNITED STATES  1.221.8   
Total revenues  485.4375.2233.211.6 
            Revenue growth   [+]29.4%60.9%1907.9%  
Cost of goods sold  0.00.00.00.0 
Gross profit  485.4375.2233.211.6 
            Gross margin  100.0%100.0%100.0%100.0% 
Selling, general and administrative   [+]66.848.815.84.0 
Research and development  107.962.129.410.1 
Other operating expenses  94.360.032.0  
EBITDA   [+]244.4233.3160.9-2.5 
            EBITDA margin  50.3%62.2%69.0%-21.6% 
Depreciation  17.318.82.31.6 
EBITA  227.0214.5158.5-4.1 
            EBITA margin  46.8%57.2%68.0%-35.5% 
Amortization of intangibles  10.510.12.5  
EBIT   [+]216.5204.4156.0-4.1 
            EBIT margin  44.6%54.5%66.9%-35.5% 
Interest income  16.13.30.30.2 
Other income (expense), net   [+]6.511.41.51.8 
Pre-tax income  239.1219.1157.8-2.2 
Income taxes  80.665.738.90.0 
            Tax rate  33.7%30.0%24.7%0.0% 
Net income  158.5153.5118.9-2.2 
            Net margin  32.7%40.9%51.0%-19.0% 
   
Basic EPS   [+]$0.56$0.56$0.75($0.01) 
Diluted EPS   [+]$0.50$0.48$0.45($0.01) 
   
Shares outstanding (basic)   [+]285.1275.8159.2151.3 
Shares outstanding (diluted)   [+]314.8318.3263.1151.3 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy